
To update the American Society of Clinical Oncology zzso Technology Assessment guidelines on chemotherapy sensitivity and resistance zzso zzso published in zzso 

An zzso Working Group reviewed data published between December 1, 2003, and May 31, zzso zzso and the Cochrane Library were zzso The literature search yielded zzso new zzso The limits for zzso and zzso were used, and then standard zzso search strings for zzso controlled trials, zzso guidelines, and reviews were added, yielding zzso articles for abstract zzso Of these, only 21 articles met zzso inclusion criteria and underwent full text review, and five reports of zzso controlled trials were included for data zzso 

Review of the literature does not identify any zzso for which the evidence base is sufficient to support use in zzso zzso 

The use of zzso to select zzso agents for individual patients is not recommended outside of the clinical trial zzso zzso should make chemotherapy treatment recommendations based on published reports of clinical trials and a patient's health status and treatment zzso Because the in zzso zzso strategy has potential importance, participation in clinical trials evaluating these technologies remains a zzso 

